Table III.
Final histopathology of all FNAB cytology subdivisions
| Preoperative FNAB Cytology | ||||
|---|---|---|---|---|
| Final Diagnosis | Benign | Inconclusive | Malignant | Non-diagnostic |
| n | 52 | 23 | 11 | 11 |
| Carcinoma (%) | ||||
| PTC | 4 (7.7%) | 1 (4.3%) | 8 (72.7%) | 2 (18.2%) |
| FC | 0 | 1 (4.3%) | 0 | 0 |
| HCC | 0 | 2 (8.7%) | 0 | 1 (9.1%) |
| MTC | 0 | 0 | 1 (9.1%) | 0 |
| Anaplastic | 0 | 0 | 1 (9.1%) | 0 |
| Benign follicular neoplasm (%) | ||||
| FA | 18 (34.6%) | 13 (56.6%) | 0 | 5 (45.4%) |
| HCA | 4 (7.7%) | 3 (13.1%) | 0 | 0 |
| Benign pathology (%) | ||||
| MNG | 17 (32.7%) | 2 (8.7%) | 0 | 1 (9.1%) |
| Benign nodule/cyst | 9 (17.3%) | 1 (4.3%) | 0 | 2 (18.2%) |
| Sarcoid/noncaseating granuloma | 0 | 0 | 1 (9.1%) | 0 |
PTC, papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; HCC, Hürthle cell carcinoma; MTC, medullary thyroid carcinoma; FA, follicular adenoma; HCA, Hürthle cell carcinoma; MNG, multinodular gouter